Back to FIRST TRUST ADVISORS LP FIRST TRUST ADVISORS LP

SRPTSRPT
Showing 8 of 30 quarters

Position history for FIRST TRUST ADVISORS LPFIRST TRUST ADVISORS LP's holdings in SAREPTA THERAPEUTICS INC

FIRST TRUST ADVISORS LP holds 4.1M shares of SRPT (SAREPTA THERAPEUTICS INC), worth $90M as of 2026-Q1. The position was increased (+107.6% shares). SRPT represents 0.1% of FIRST TRUST ADVISORS LP's portfolio.

Current Value

$90M

Current Shares

4.1M

Total Value Change

+$73.9M

Total Shares Change

+4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
4.1M
+107.6%
$90M0.1%$15.87
48
2025-Q4
Increased
2M
+2.7%
$42.9M0.0%$21.49
30
2025-Q3
Increased
1.9M
+209.1%
$37.4M0.0%$18.82
47
2025-Q2
Increased
627,561
+59.2%
$10.7M0.0%$17.11
40
2025-Q1
Increased
394,170
+26.4%
$25.2M0.0%$70.41
35
2024-Q4
Decreased
311,785
-32.9%
$37.9M0.0%$121.19
0
2024-Q3
Increased
464,916
+356.2%
$58.1M0.1%$124.53
47
2024-Q2
New
101,916
-
$16.1M0.0%$158.00
39

Other major holders of SRPT: BlackRock Finance, Inc., BlackRock, Inc., Capital Research Global Investors, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used